Tolremo Therapeutics AG

https://www.tolremo.com

TOLREMO therapeutics AG is a Switzerland-based preclinical biotechnology company founded in 2017 by leading experts in the field of cancer drug resistance. The company leverages a proprietary technology platform to develop small molecules that when combined with targeted cancer agents prevent non-genetic drug resistance. The company’s lead candidate TT125-802 shows promising activity in sophisticated preclinical models as combination therapy in the prevention of cancer drug resistance in CRC and NSCLC harboring specific mutations, including KRAS. Preclinical monotherapy activity has been shown for selected solid tumors and hematological malignancies. The compound bears the potential of broad relevance in several cancer indications where standard of care treatments are currently limited by the rapid development of resistance. TOLREMO’s platform aims to deliver therapies to complement standard cancer therapies to offer better response rates, longer survival and an improved quality of life to patients with cancer. *

	Start	2017-03-01 established
	Predecessor	ETH Zürich (ETHZ)
	Industry	cancer drug
	Person	Flückiger-Mangual, Stefanie (201809 CEO + Co-Founder)

	Region	Muttenz BL
	Country	Switzerland
	Street	40B Hofackerstr.
	City	4132 Muttenz BL
		Address record changed: 2022-07-11

Basic data	Employees	A: 1 to 10 (2019-01-01)

		* Document for »About Section«: Tolremo Therapeutics AG. (6/22/22). "Press Release: Tolremo Therapeutics AG Announces Appointment of Dr. Karl Schumacher as Chief Medical Officer". Muttenz.

		Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Tolremo Therapeutics AG

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)